Mindset Pharma Receives Allowance for U.S. Patent Application Covering Composition of Matter for Its…
TORONTO, Jan. 20, 2023 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or…
Read More...
Read More...
Browsing Tag
Mindset Pharma Inc.
Mindset Pharma Presents Poster at Neuroscience 2022 Highlighting Preclinical Data on MSP-1014, its…
TORONTO, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or…
Read More...
Read More...
Mindset Pharma Aims to Treat Broader Addressable Neurology Market by Studying Cognitive Benefits of…
Mindset’s Family 3 of next-generation psilocybin compounds have demonstrated low levels of activity at the 5-HT2A…
Read More...
Read More...
Mindset Pharma Recaps 2021 Milestones and Highlights
Evolving Pipeline of Psychedelic Compounds Focused on Improved Efficacy and Safety Advancing MSP-1014 as First…
Read More...
Read More...
Mindset Pharma Announces Filing of International Patent Application Covering its Family 3…
TORONTO, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) ("Mindset" or…
Read More...
Read More...